The U.K.’s accounting watchdog is investigating Deloitte LLP’s work on Glencore Plc and a U.K. unit, amid corruption scandals involving the commodity giant.
It faces a potential $4.6 billion in additional taxes owed after an accounting change, although it is contesting the matter with the Internal Revenue Service.
Staffing shortfalls and intricate new policies are complicating efforts at the Treasury and IRS to meet tight deadlines for churning out guidance on the tax bill.
Karbon hailed the launch of Karbon for Clients, touted as an end-to-end solution that manages the entire client lifecycle from onboarding to delivery to long-term relationship management.
Sarepta Therapeutics faces serious FDA action after news broke of a third patient death, the FDA gets a new top drug regulator in George Tidmarsh, a handful of new drugs get turned away from the market and pharma companies continue to commit billions to reshoring manufacturing.
ADARx Pharmaceuticals CEO Zhen Li found her way to biopharma through Merck, where she was inspired by the application of powerful science to human medicine.